Patents by Inventor Ian Buxton

Ian Buxton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120142651
    Abstract: There is provided a method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof, wherein the administration is once-per-day and intranasal, and the total daily dose of the compound (I) is 50 to 100 ?g.
    Type: Application
    Filed: February 10, 2012
    Publication date: June 7, 2012
    Applicant: GlaxoSmithKline Intellectual Property Management Limited
    Inventors: Keith Biggadike, Ian Buxton, Steven John Coote, Rosalyn Kay Nice, Kenton Lewis Reed, Amyn Sayani, Avinash Chander Sharma
  • Publication number: 20100311706
    Abstract: There is provided a method of treatment of allergic rhinitis which comprises administering to a patient a pharmaceutically acceptable amount of a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof, wherein the administration is once-per-day and intranasal, and the total daily dose of the compound (I) is 50 to 100 ?g.
    Type: Application
    Filed: August 18, 2010
    Publication date: December 9, 2010
    Applicant: GLAXO GROUP LIMITED
    Inventors: Keith Biggadike, Ian Buxton, Steven John Coote, Rosalyn Kay Nice, Kenton Lewis Reed, Amyn Sayani, Avinash Chander Sharma
  • Patent number: 7531528
    Abstract: There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein (a) an ester of fluticasone or a solvate thereof as medicament and (b) a solubilizing agent for assisting the solubilization of the medicament in the aqueous carrier liquid.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: May 12, 2009
    Assignee: Glaxo Group Limited
    Inventors: Keith Biggadike, Amyn Sayani, Ian Buxton, Kenton Reed
  • Publication number: 20050209206
    Abstract: A pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein (a) a glucocorticoid of formula (I) wherein R represents a 5 membered heterocyclic aromatic ring containing 1 to 3 heteroatoms selected from O, N and S, optionally substituted by one or more methyl or halogen atoms or a solvate thereof, as a medicament; and (b) a solubilising agent for assisting the solubilisation of the medicament in the aqueous carrier liquid.
    Type: Application
    Filed: February 4, 2003
    Publication date: September 22, 2005
    Inventors: Keith Biggadike, Ian Buxton, Peter Daley-Yates, Bettina Fong, Elita Ho, Kenton Reed, Amyn Sayani
  • Publication number: 20050164996
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
    Type: Application
    Filed: February 4, 2003
    Publication date: July 28, 2005
    Inventors: Keith Biggadike, Ian Buxton, Steven Coote, Rosalyn Nice, Kenton Reed, Amyn Sayani, Avinash Sharma
  • Publication number: 20050032799
    Abstract: A sustained release formulation of lamotrigine or a pharmaceutically acceptable derivative thereof and methods of treatment and uses thereof.
    Type: Application
    Filed: July 29, 2003
    Publication date: February 10, 2005
    Inventors: Ian Buxton, Robin Currie, Myrna Dela-Cruz, Gary Goodson, Wlodzimierz Karolak, Mehran Maleki, Vijay Iyer, Gopal Muppirala, Alan Parr, Jagdev Sidhu, Robert Stagner, Akunuri Vijay-Kumar
  • Publication number: 20050026888
    Abstract: There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein (a) an ester of fluticasone or a solvate thereof as medicament and (b) a solubilising agent for assisting the solubilisation of the medicament in the aqueous carrier liquid.
    Type: Application
    Filed: August 13, 2004
    Publication date: February 3, 2005
    Inventors: Keith Biggadike, Amyn Sayani, Ian Buxton, Kenton Reed
  • Publication number: 20050020549
    Abstract: There is provided a pharmaceutical formulation comprising an aqueous suspension of particulate compound of formula (I) or a solvate thereof.
    Type: Application
    Filed: August 13, 2004
    Publication date: January 27, 2005
    Inventors: Keith Biggadike, Amyn Sayani, Ian Buxton, Kenton Reed
  • Patent number: 6787532
    Abstract: There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein (a) an ester of fluticasone or a solvate thereof as medicament and (b) a solubilising agent for assisting the solubilisation of the medicament in the aqueous carrier liquid.
    Type: Grant
    Filed: February 4, 2002
    Date of Patent: September 7, 2004
    Assignee: SmithKline Beecham Corporation
    Inventors: Keith Biggadike, Amyn P. Sayani, Ian Buxton, Kenton Reed
  • Publication number: 20030073676
    Abstract: There is provided according to the invention a pharmaceutical formulation comprising an aqueous carrier liquid having dissolved therein (a) an ester of fluticasone or a solvate thereof as medicament and (b) a solubilising agent for assisting the solubilisation of the medicament in the aqueous carrier liquid.
    Type: Application
    Filed: February 4, 2002
    Publication date: April 17, 2003
    Inventors: Keith Biggadike, Amyn P. Sayani, Ian Buxton, Kenton Reed